The Conversation (0)
MarketWatch reported that analysts are generative positive towards Israel Chemicals (TLV:ICL) despite having some questions about the company’s performance.
MarketWatch reported that analysts are generative positive towards Israel Chemicals (TLV:ICL) despite having some questions about the company’s performance.
As quoted in the market news:
One bull on ICL is analyst Joseph Wolf at Barclays Capital, who reiterated an overweight rating on the stock with a 60-shekel price target. The shares on Thursday closed down 1.1% at 43.2 shekels ($11.56).